SPOTLIGHT -
Mycamine from Astellas Pharma was given a supplemental indication approval
At-home COVID-19 Test Cue OTC Receives Marketing Authorization from FDA
The newly approved at-home test was effective in trials, correctly identifying 98.7% of negative and 92.9% of positive samples for individuals with symptoms of upper respiratory infection.
RPhCast, Episode One: Statins, Blood Pressure, and Curves Galore
Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.
NCCN Calls on Federal Agencies, Payers, to Take Action on Chemotherapy Drug Shortages
Carboplatin and cisplatin are currently in short supply.
How Independent Pharmacists Build Their Brand In A Crowded Market
Drug Topics® is joined by Thomas W. Taylor, the owner of Williamsburg Drug, for a conversation about starting an independent pharmacy, maintaining patient relationships, and more.
Wildfire Smoke Raises Respiratory Concerns Across Northeastern United States
Air quality in New York City was the worst in the world on Tuesday morning.
The Price of New Cancer Drugs Continues To Rise
The median annual cost for new oncology medicines launched in 2022 was $260,000, up from $63,534 10 years ago, an IQVIA report finds.